Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LucyTx-1209
- Development stage
- Preclinical
- Lead developer
- Lucy Therapeutics
- Modality
- Small Molecules
- Administration
- Unknown
01
Overview
LucyTx-1209 is a preclinical, proprietary small molecule drug candidate developed by Lucy Therapeutics. Designed to target mitochondrial dysfunction, it acts by selectively inhibiting the F1F0-ATPase complex (part of the mitochondrial electron transport chain) to reverse mitochondrial deficits implicated in neurodegenerative diseases, notably Parkinson’s disease. In preclinical studies, LucyTx-1209 has shown potential to restore neuronal health by improving mitochondrial function, enhancing cellular ATP production, rescuing neurons, and reducing pathogenic alpha-synuclein accumulation. The compound is also part of broader research efforts at Lucy Therapeutics for diseases such as Alzheimer's disease and Rett syndrome[1][2][3][4][7][9].
- Other names
- LucyTx-1209LucyTx1209LucyTx 1209
02
Targets
ATP Synthase
Beyond the preview
Go deeper on LucyTx-1209.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LucyTx-1209.